ICU Medical, Inc. (NASDAQ:ICUI) COO Christian B. Voigtlander Sells 4,985 Shares

ICU Medical, Inc. (NASDAQ:ICUI) COO Christian B. Voigtlander sold 4,985 shares of the business’s stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $128.50, for a total value of $640,572.50. Following the sale, the chief operating officer now owns 6,088 shares in the company, valued at approximately $782,308. The trade was a 45.02% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

ICU Medical Stock Down 2.1%

Shares of ICU Medical stock traded down $2.73 during trading on Wednesday, reaching $127.72. The company had a trading volume of 55,063 shares, compared to its average volume of 276,698. The company has a market cap of $3.14 billion, a price-to-earnings ratio of -27.95 and a beta of 0.87. The firm’s fifty day moving average is $138.87 and its 200-day moving average is $151.88. ICU Medical, Inc. has a fifty-two week low of $100.91 and a fifty-two week high of $196.26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

ICU Medical (NASDAQ:ICUI) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 EPS for the quarter, beating the consensus estimate of $1.23 by $0.49. ICU Medical had a negative net margin of 4.74% and a positive return on equity of 5.05%. The firm had revenue of $599.49 million for the quarter, compared to analysts’ expectations of $574.15 million. During the same quarter last year, the company earned $0.96 EPS. ICU Medical’s quarterly revenue was up 6.7% on a year-over-year basis. On average, analysts anticipate that ICU Medical, Inc. will post 4.11 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have commented on ICUI shares. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a report on Tuesday, April 8th. Wall Street Zen upgraded ICU Medical from a “hold” rating to a “buy” rating in a research report on Sunday, May 18th. KeyCorp decreased their price objective on shares of ICU Medical from $209.00 to $191.00 and set an “overweight” rating on the stock in a report on Monday, April 21st. Finally, Raymond James cut their target price on shares of ICU Medical from $197.00 to $187.00 and set a “strong-buy” rating for the company in a research report on Friday, May 9th. One investment analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, ICU Medical presently has an average rating of “Buy” and a consensus price target of $192.67.

Institutional Investors Weigh In On ICU Medical

Several institutional investors have recently made changes to their positions in the company. Arizona State Retirement System lifted its position in ICU Medical by 1.0% during the 4th quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier’s stock worth $1,044,000 after acquiring an additional 65 shares during the last quarter. Huntington National Bank lifted its holdings in ICU Medical by 6.2% during the 4th quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier’s stock worth $218,000 after buying an additional 82 shares in the last quarter. Equitable Trust Co. raised its stake in shares of ICU Medical by 1.6% during the fourth quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier’s stock worth $822,000 after buying an additional 84 shares during the last quarter. Xponance Inc. lifted its stake in ICU Medical by 5.3% in the first quarter. Xponance Inc. now owns 1,714 shares of the medical instruments supplier’s stock valued at $238,000 after buying an additional 86 shares during the period. Finally, LPL Financial LLC grew its holdings in shares of ICU Medical by 2.0% in the 4th quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier’s stock valued at $747,000 after buying an additional 93 shares during the period. 96.10% of the stock is currently owned by institutional investors and hedge funds.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.